Covid-19 Research

Mini Review

Radiological and Chemoteraphy Hints in Ovarian Lymphoma: A Mini Literature Review

Journal of Biomedical Research & Environmental Sciences article abstract with citation details, DOI, publication dates, subject areas, full text links, and references.

View DOI Submit Manuscript

Article Details

Publication record, authors, dates, abstract, and full text access.

Open Access
Article Type Mini Review
Subject Medicine Group
OCLC JBRES Record
Diana Donatello*
Issue: Volume4-Issue12
Pages: 1764-1768
Received: 2023-12-25
Accepted: 2023-12-30
Published: 2023-12-31

Abstract

Introduction: In this mini review we analized some cases of Ovarian Lymphoma (OL) offprint from the previous literature, both primary and secondary.

Discussion: We know that a standard method of staging and follow-up in non-Hodgkin's lymphomas is PET/CT, which, however, due to the limited presence of ovarian lymphomas in the population, is not present in the literature as a primary tool in the diagnosis of this type of neoplasm. The first suspected dignosis is often done with US, CT or MRI, but the gold standard remains the biopsy. As regards for the chemotheraphy those cases poin out the non-toxicity of rituximab and its possible routinary use in the treatment of OL.

Conclusion: US, CT and MRI are the first diagnostic tools in the diagnosis of OL. Nowadays PET/CT is used in the staging and follow-up of OL. The R-CHOP protocol can be utilized in the treatment of OL, reducing the use of readioteraphy. Gynecologists must be aware of this rare ovarian tumor in order to avoid unnecessary radical surgery.

FullText HTML FullText PDF DOI: 10.37871/jbres1862 Crossmark

Certificate of Publication

Certificate of Publication

Copyright

© 2023 Donatello D. Distributed under Creative Commons CC-BY 4.0 Creative CommonsAttribution

How to cite this article

Donatello D. Radiological and Chemoteraphy Hints in Ovarian Lymphoma: A Mini Literature Review. J Biomed Res Environ Sci. 2023 Dec 31; 4(12): 1764-1768. doi: 10.37871/jbres1862, Article ID: JBRES1862, Available at: https://www.jelsciences. com/articles/jbres1862.pdf

Subject area(s)

GynecologyCancer

References

  1. Ahbeddou N, Fetohi M, Khanoussi BE, Errihani H. Rituximab CHOP for successful management of diffuse large B-cell lymphoma of the ovary. Arch Gynecol Obstet. 2011 May;283(5):1173-4. doi: 10.1007/s00404-010-1701-0. Epub 2010 Oct 19. PMID: 20957380.
  2. Signorelli M, Maneo A, Cammarota S, Isimbaldi G, Garcia Parra R, Perego P, Maria Pogliani E, Mangioni C. Conservative management in primary genital lymphomas: the role of chemotherapy. Gynecol Oncol. 2007 Feb;104(2):416-21. doi: 10.1016/j.ygyno.2006.08.024. Epub 2006 Oct 16. PMID: 17049970.
  3. Niitsu N, Nakamine H, Hayama M, Unno Y, Nakamura S, Horie R, Iwabuchi K, Nakamura N, Miura I, Higashihara M. Ovarian follicular lymphoma: a case report and review of the literature. Ann Hematol. 2002 Nov;81(11):654-8. doi: 10.1007/s00277-002-0545-5. Epub 2002 Oct 12. PMID: 12454705.
  4. Komoto D, Nishiyama Y, Yamamoto Y, Monden T, Sasakawa Y, Toyama Y, Satoh K, Ohno M, Kanenishi K, Ohkawa M. A case of non-hodgkin's lymphoma of the ovary: usefulness of 18F-FDG PET for staging and assessment of the therapeutic response. Ann Nucl Med. 2006 Feb;20(2):157-60. doi: 10.1007/BF02985629. PMID: 16615426.
Publish with JBRES — Peer-reviewed, multidisciplinary Open Access with rapid review, DOI, and global visibility.
Double-Blind CrossRef DOI Discoverable
Submit Manuscript Membership